vs
Axsome Therapeutics, Inc.（AXSM）与Revolve Group, Inc.（RVLV）财务数据对比。点击上方公司名可切换其他公司
Revolve Group, Inc.的季度营收约是Axsome Therapeutics, Inc.的1.7倍（$324.4M vs $196.0M），Revolve Group, Inc.净利率更高（5.7% vs -14.6%，领先20.3%），Axsome Therapeutics, Inc.同比增速更快（65.0% vs 10.4%），Revolve Group, Inc.自由现金流更多（$-13.3M vs $-18.7M），过去两年Axsome Therapeutics, Inc.的营收复合增速更高（61.7% vs 9.5%）
Jazz Pharmaceuticals是一家全球生物制药企业，专注于肿瘤学与神经科学领域的药物研发及商业化。公司2003年在美国加利福尼亚州成立，目前总部位于爱尔兰都柏林，业务覆盖全球多个核心市场。
Revolve Theatre Company是总部位于英国泰晤士河畔亨利的剧团，专注于创作演出政治题材和莎士比亚系列戏剧作品，由奥利弗·登奇、乔·莫里斯与汤姆·史密斯共同创立运营。
AXSM vs RVLV — 直观对比
营收规模更大
RVLV
是对方的1.7倍
$196.0M
营收增速更快
AXSM
高出54.6%
10.4%
净利率更高
RVLV
高出20.3%
-14.6%
自由现金流更多
RVLV
多$5.4M
$-18.7M
两年增速更快
AXSM
近两年复合增速
9.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $196.0M | $324.4M |
| 净利润 | $-28.6M | $18.6M |
| 毛利率 | — | 53.3% |
| 营业利润率 | -13.8% | 6.3% |
| 净利率 | -14.6% | 5.7% |
| 营收同比 | 65.0% | 10.4% |
| 净利润同比 | 61.9% | 50.4% |
| 每股收益（稀释后） | $-0.55 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXSMRVLV
| Q4 25 | $196.0M | $324.4M | ||
| Q3 25 | $171.0M | $295.6M | ||
| Q2 25 | $150.0M | $309.0M | ||
| Q1 25 | $121.5M | $296.7M | ||
| Q4 24 | $118.8M | $293.7M | ||
| Q3 24 | $104.8M | $283.1M | ||
| Q2 24 | $87.2M | $282.5M | ||
| Q1 24 | $75.0M | $270.6M |
净利润AXSMRVLV
| Q4 25 | $-28.6M | $18.6M | ||
| Q3 25 | $-47.2M | $21.2M | ||
| Q2 25 | $-48.0M | $10.2M | ||
| Q1 25 | $-59.4M | $11.8M | ||
| Q4 24 | $-74.9M | $12.3M | ||
| Q3 24 | $-64.6M | $11.0M | ||
| Q2 24 | $-79.3M | $15.4M | ||
| Q1 24 | $-68.4M | $10.9M |
毛利率AXSMRVLV
| Q4 25 | — | 53.3% | ||
| Q3 25 | — | 54.6% | ||
| Q2 25 | — | 54.1% | ||
| Q1 25 | — | 52.0% | ||
| Q4 24 | — | 52.5% | ||
| Q3 24 | — | 51.2% | ||
| Q2 24 | — | 54.0% | ||
| Q1 24 | — | 52.3% |
营业利润率AXSMRVLV
| Q4 25 | -13.8% | 6.3% | ||
| Q3 25 | -27.0% | 7.1% | ||
| Q2 25 | -24.5% | 5.8% | ||
| Q1 25 | -46.9% | 5.0% | ||
| Q4 24 | -61.1% | 3.9% | ||
| Q3 24 | -59.8% | 5.0% | ||
| Q2 24 | -89.5% | 5.8% | ||
| Q1 24 | -89.7% | 3.4% |
净利率AXSMRVLV
| Q4 25 | -14.6% | 5.7% | ||
| Q3 25 | -27.6% | 7.2% | ||
| Q2 25 | -32.0% | 3.3% | ||
| Q1 25 | -48.9% | 4.0% | ||
| Q4 24 | -63.1% | 4.2% | ||
| Q3 24 | -61.7% | 3.9% | ||
| Q2 24 | -91.0% | 5.4% | ||
| Q1 24 | -91.1% | 4.0% |
每股收益（稀释后）AXSMRVLV
| Q4 25 | $-0.55 | $0.27 | ||
| Q3 25 | $-0.94 | $0.29 | ||
| Q2 25 | $-0.97 | $0.14 | ||
| Q1 25 | $-1.22 | $0.16 | ||
| Q4 24 | $-1.54 | $0.18 | ||
| Q3 24 | $-1.34 | $0.15 | ||
| Q2 24 | $-1.67 | $0.21 | ||
| Q1 24 | $-1.44 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $322.9M | $292.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $88.3M | $512.5M |
| 总资产 | $689.8M | $765.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AXSMRVLV
| Q4 25 | $322.9M | $292.3M | ||
| Q3 25 | $325.3M | $315.4M | ||
| Q2 25 | $303.0M | $310.7M | ||
| Q1 25 | $300.9M | $300.8M | ||
| Q4 24 | $315.4M | $256.6M | ||
| Q3 24 | $327.3M | $252.8M | ||
| Q2 24 | $315.7M | $244.7M | ||
| Q1 24 | $331.4M | $273.4M |
股东权益AXSMRVLV
| Q4 25 | $88.3M | $512.5M | ||
| Q3 25 | $73.7M | $490.2M | ||
| Q2 25 | $73.1M | $468.6M | ||
| Q1 25 | $53.2M | $453.4M | ||
| Q4 24 | $57.0M | $437.8M | ||
| Q3 24 | $92.9M | $420.8M | ||
| Q2 24 | $102.9M | $405.8M | ||
| Q1 24 | $144.0M | $389.9M |
总资产AXSMRVLV
| Q4 25 | $689.8M | $765.0M | ||
| Q3 25 | $669.3M | $751.3M | ||
| Q2 25 | $639.8M | $722.9M | ||
| Q1 25 | $596.7M | $713.9M | ||
| Q4 24 | $568.5M | $665.5M | ||
| Q3 24 | $561.5M | $670.9M | ||
| Q2 24 | $548.2M | $657.8M | ||
| Q1 24 | $545.7M | $650.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-18.7M | $-10.2M |
| 自由现金流经营现金流 - 资本支出 | $-18.7M | $-13.3M |
| 自由现金流率自由现金流/营收 | -9.6% | -4.1% |
| 资本支出强度资本支出/营收 | 0.0% | 1.0% |
| 现金转化率经营现金流/净利润 | — | -0.55× |
| 过去12个月自由现金流最近4个季度 | $-93.9M | $48.0M |
8季度趋势，按日历期对齐
经营现金流AXSMRVLV
| Q4 25 | $-18.7M | $-10.2M | ||
| Q3 25 | $1.0M | $11.8M | ||
| Q2 25 | $-32.4M | $12.6M | ||
| Q1 25 | $-43.4M | $45.1M | ||
| Q4 24 | $-26.2M | $3.9M | ||
| Q3 24 | $-18.6M | $9.1M | ||
| Q2 24 | $-30.1M | $-24.7M | ||
| Q1 24 | $-53.5M | $38.4M |
自由现金流AXSMRVLV
| Q4 25 | $-18.7M | $-13.3M | ||
| Q3 25 | $988.0K | $7.5M | ||
| Q2 25 | $-32.4M | $10.4M | ||
| Q1 25 | $-43.7M | $43.4M | ||
| Q4 24 | $-26.2M | $2.1M | ||
| Q3 24 | $-18.7M | $8.0M | ||
| Q2 24 | $-30.2M | $-25.7M | ||
| Q1 24 | $-53.6M | $36.7M |
自由现金流率AXSMRVLV
| Q4 25 | -9.6% | -4.1% | ||
| Q3 25 | 0.6% | 2.5% | ||
| Q2 25 | -21.6% | 3.4% | ||
| Q1 25 | -36.0% | 14.6% | ||
| Q4 24 | -22.1% | 0.7% | ||
| Q3 24 | -17.9% | 2.8% | ||
| Q2 24 | -34.6% | -9.1% | ||
| Q1 24 | -71.4% | 13.5% |
资本支出强度AXSMRVLV
| Q4 25 | 0.0% | 1.0% | ||
| Q3 25 | 0.0% | 1.5% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | 0.3% | 0.6% | ||
| Q4 24 | 0.0% | 0.6% | ||
| Q3 24 | 0.1% | 0.4% | ||
| Q2 24 | 0.1% | 0.4% | ||
| Q1 24 | 0.1% | 0.6% |
现金转化率AXSMRVLV
| Q4 25 | — | -0.55× | ||
| Q3 25 | — | 0.56× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 3.82× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | -1.60× | ||
| Q1 24 | — | 3.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXSM
暂无分部数据
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
